Logo-ipp

Immunopathol Persa. 2021;7(2): e16. doi: 10.34172/ipp.2021.16

Original

New therapy for chemotherapy-induced hepatic failure in leukemia; a randomized double-blind clinical trial study

Farid Ghazizadeh 1 ORCID, Mehran Noroozi 1 * ORCID, Parvaneh Shadara 2 ORCID, Javad Rasouli 3 ORCID, Sasan Hejazi 1 ORCID

Cited by CrossRef: 1

1- Ghodousi M, Karbasforooshan H, Arabi L, Elyasi S. Silymarin as a preventive or therapeutic measure for chemotherapy and radiotherapy-induced adverse reactions: a comprehensive review of preclinical and clinical data. Eur J Clin Pharmacol. 2023;79(1):15 [Crossref]